Evidence map›Paper›PMID 38895928›Full record

ArticleJournal of magnetic resonance imaging : JMRI2025

Enhancing Tumor Microstructural Quantification With Machine Learning and Diffusion-Relaxation MRI.

Carlos Macarro, Kinga Bernatowicz, Alonso Garcia-Ruiz, Garazi Serna, Camilo Monreal-Agüero, Sara Simonetti, Matteo Figini, Juan Francisco Corral, Valezka Garay, Marta Vidorreta and 12 more

Abstract readLetter
In one paragraph

Article in Journal of magnetic resonance imaging : JMRI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Carlos MacarroVall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Kinga BernatowiczVall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Alonso Garcia-RuizVall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Garazi SernaVall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Camilo Monreal-AgüeroVall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Sara SimonettiVall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Matteo FiginiCentre for Medical Image Computing, Department of Computer Science, University College London, London, UK.ORCID https://orcid.org/0000-0002-8238-2262
Juan Francisco CorralDepartment of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Valezka GarayPET/MR Unit, CETIR-Ascires, Barcelona, Spain.
Marta VidorretaSiemens Healthineers, Madrid, Spain.
Pablo García-Polo GarcíaGE HealthCare, Madrid, Spain.
Xavier MerinoDepartment of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Richard MastDepartment of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Núria RosonDepartment of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Maria VieitoVall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Manuel EscobarDepartment of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Daniel C AlexanderCentre for Medical Image Computing, Department of Computer Science, University College London, London, UK.
Rodrigo ToledoVall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Paolo NuciforoVall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Elena GarraldaVall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Raquel Perez-LopezVall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Francesco GrussuVall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID https://orcid.org/0000-0002-0945-3909

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya 2019 BP 00182Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya 2023PROD00178Agencia Estatal de Investigación CEX2020-001024-S/AEI/10.13039/501100011033AstraZeneca PREdICTCellex FoundationCERCA Programme from the Generalitat de CatalunyaComissió Interdepartamental de Recerca i Innovació TecnològicaCRIS Cancer Foundation TALENT19-05European Regional Development FundFERO Foundation through the XVIII Fero Fellowship for Oncological ResearchFundación Científica Asociación Española Contra el Cáncer (AECC) PRYCO211023SERRInstituto de Salud Carlos III PI18/01395Instituto de Salud Carlos III PI21/01019'la Caixa' Foundation LCF/BQ/PR22/11920010'la Caixa' Foundation - : CaixaResearch Advanced Oncology Research ProgramMarie Sklodowska-Curie COFUND program BP3801370Prostate Cancer Foundation 18YOUN19Secretariat of Universities and Research of the Department of Business and Knowledge of the Government of Catalonia
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38895928
PMCPMC11706317

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.